Royce & Associates’s Concentrix CNXC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-10,405
Closed -$1.86M 967
2021
Q4
$1.86M Sell
10,405
-14,586
-58% -$2.6M 0.01% 736
2021
Q3
$4.42M Sell
24,991
-8,500
-25% -$1.41M 0.03% 615
2021
Q2
$5.38M Sell
33,491
-16,100
-32% -$2.48M 0.04% 597
2021
Q1
$7.42M Sell
49,591
-43,217
-47% -$5.24M 0.05% 518
2020
Q4
$9.16M Buy
+92,808
New +$9.28M 0.08% 395

Other funds holding CNXC

Royce & Associates's CNXC Position: Q1 2022 in Review

Royce & Associates sold out of Concentrix (CNXC) in Q1 2022, closing a stake of 10,405 shares — an estimated $1.86M sold.

Royce & Associates first reported a position in CNXC in Q4 2020 and held it in 5 quarters. The position peaked at $9.16M in Q4 2020. 353 funds tracked by Wall St. Rank hold CNXC as of Q1 2022.

  • Royce & Associates reported no remaining Concentrix position as of Q1 2022 after selling out during the quarter.
  • Royce & Associates sold 10,405 Concentrix shares in Q1 2022, an estimated $1.86M.
  • Royce & Associates first reported a position in Concentrix in Q4 2020 and held it in 5 quarters.
  • Royce & Associates's Concentrix position peaked at $9.16M in Q4 2020.
  • 353 funds tracked by Wall St. Rank held Concentrix as of Q1 2022.

Based on Royce & Associates's 13F filing for Q1 2022, filed 5 May 2022.